11/19/2015 - 11:19am

Dunton’s 33 years in the industry has seen him working on discovering and developing prescription and OTC products, leading the biotechnology company Danerius since 2006 when he founded it. 

11/19/2015 - 10:45am

AccessHealth has developed an extensive guide that outlines the 2016 Medicare reimbursement, direct and indirect remuneration details.

11/18/2015 - 11:49am

AxelaCare enhances OptumRx’s ability to deliver care to the growing number of consumers managing complex conditions through at-home infusions.

11/18/2015 - 10:32am
The dispensing rate of generic medicines will increase from 88% to as high as 92% by 2020, the IMS Institute for Healthcare Informatics reported
11/18/2015 - 7:59am

Steven Collis has served as president and CEO of AmerisourceBergen since July 2011 and a director since May 2011.

11/17/2015 - 2:29pm

Mylan has launched its generic of Axert, a treatment for migraines. 

11/17/2015 - 12:58pm

Ajanta is launching its fifth generic product in the U.S. that has received Food and Drug administration approval. 

11/17/2015 - 9:16am

Tagrisso is an EGFR-tyrosine kinase inhibitor, a targeted cancer therapy, designed to inhibit both the activating, sensitizing mutations, and T790M, the genetic mutation responsible for EGFR-TKI treatment resistance in up to approximately two-thirds of cases of EGFRm advanced NSCLC. 

11/16/2015 - 2:56pm

The drug is meant to be used on-demand to control bleeding episodes and as a way to reduce their frequency.